Transgenex Nanobiotech, Inc.

TAMPA, FL 33613
http://www.transgenex.com
8 Employees

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.68MM
First Award Date 09/15/04
Most Recent Award Date 09/22/15

Key Personnel

Last Name Name Awards Contact
Xu Dr. Weidong Xu 3 Message
Mohapatra Shyam S Mohapatra 2
Mohapatra Subhra Mohapatra 1
NAIR RAJESH NAIR 1

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/22/15 - 06/21/16

TransGenex Nanobiotech (TGN) Inc proposes to further engineer and investigate the potential of a novel fiber inspired smart scaffold to expand cancer stem cells (CSCs), the FiSSCSC platform, for commercialization. CSCs comprising about <1% of cells in tumors escape conventional cancer therapies due to their drug resistance capability and cause c...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 09/11/09 - 08/31/11

DESCRIPTION (provided by applicant): The main goal of this proposal is to design novel treatments for prostate cancer (PCa) that employ specific targeting of curcumin and genistein nanocomplexes to PCa cells. Prostate cancer is the third leading cause of death among men in America. While androgen deprivation has been found to be effective in tre...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 09/01/08 - 11/30/09

DESCRIPTION (provided by applicant): According to estimates by the Joint United Nations Program on HIV/AIDS (UNAIDS), approximately 40 million people will be living with HIV/AIDS worldwide by the end of 2006. However, safe and effective AIDS vaccine remains difficult to develop. Small interference RNA (siRNA) has emerged as a powerful tool in ge...

Phase 2 SBIR

Agency: Army
Topic: A05-177
Budget: 09/06/06 - 11/20/08

Identification of effective treatments is urgently needed to provide patients with better options in treating ovarian cancer, which afflicts 25,580 Americans annually. Ovarian cancer is caused by genetic alternations; therefore, gene therapy offers a promising approach for the treatment of ovarian cancer. Transgenex Nanobiotech (TGN) Inc has de...

Phase 1 SBIR

Agency: Army
Topic: A05-177
Budget: 11/21/05 - 06/20/06

Ovarian cancer is a serious threat and ranks among the top leading causes of cancer deaths among women in the United States. Ovarian cancer is normally considered to be the result of genetic alterations. Therefore, gene therapy offers a promising approach for the treatment of ovarian cancer. Herein we propose to combine nanotechnology and the no...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/27/04 - 02/28/06

DESCRIPTION (provided by applicant): The overall goal of this proposal is to develop a human-friendly and less-expensive method of prophylaxis for respiratory syncytial virus (RSV) infection and other respiratory viruses using intranasal administration of chitosan nanoparticles containing pDNA, which allows de novo expression of IFNs. Forty-five...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/04 - 02/28/06

DESCRIPTION (provided by applicant): In an effort to develop a better treatment for allergic diseases, including asthma and allergic rhinitis, our goal is to examine the efficacy and safety of chliposome IFN-( gene nanoparticle (CLIN) Therapy. This proposal is based on the two major developments in potential use of gene therapy for asthma: (i) c...